The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Update of the 2006 Evidence-Based Review

Biology of Blood and Marrow Transplantation

Volumn 18, Issue 1, 2012, Pages 16-17

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; MYELOABLATIVE AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER SURVIVAL; CANCER THERAPY; CORD BLOOD STEM CELL TRANSPLANTATION; EVIDENCE BASED MEDICINE; EVIDENCE BASED PRACTICE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA REMISSION; MYELOABLATIVE CONDITIONING; NOTE;

COMBINED MODALITY THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TREATMENT OUTCOME;

EID: 84855423309     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.09.002     Document Type: Note

References (2)

1. Oliansky D.M., Larson R.A., Weisdorf D., et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: update of the 2006 evidence-based review. Biol Blood Marrow Transplant 2011, 18:19-37.
2. Hahn T., Wall D., Camitta B., et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review. Biol Blood Marrow Transplant 2006, 12:1-30.